Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder

Slide deck
par
Oviedo-Joekes, Eugenia

Date de publication

2018

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

No

L’objectif

The aim of this presentation is to examine the safety profile of injectable
hydromorphone and diacetylmorphine by analyzing rates of adverse
events (AEs) in the SALOME study and exploring if they were
associated with dose and patterns of treatment attendance.

Constatations/points à retenir

When injectable hydromorphone and diacetylmorphine are individually dosed and monitored, their opioid-related side effects, including potential fatal overdoses, are safely mitigated and treated by health care providers. Related adverse events did not lead to more missed treatment days and the dose prescribed does not seem to play a direct or sole role.

Mots clés

Safer supply
Evidence base
Overdose
Outcomes